help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on June 15, 2007, doi:10.1165/rcmb.2006-0276OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0276OCv1
37/4/414    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendrickson, B.
Right arrow Articles by Lutzko, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendrickson, B.
Right arrow Articles by Lutzko, C.
American Journal of Respiratory Cell and Molecular Biology. Vol. 37, pp. 414-423, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2006-0276OC

Development of Lentiviral Vectors with Regulated Respiratory Epithelial Expression In Vivo

Benjamin Hendrickson1,*, Dinithi Senadheera1,*, Suparna Mishra1, Kim Chi T. Bui2, XingChao Wang1, Belinda Chan1, Denise Petersen1, Karen Pepper1 and Carolyn Lutzko1

1 Division of Research Immunology and Bone Marrow Transplantation, Department of Pediatrics and The Saban Research Institute at Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California; and 2 Department of Neonatology, Geffen School of Medicine, University of California, Los Angeles, California

Correspondence and requests for reprints should be addressed to Carolyn Lutzko, PhD, Childrens Hospital Los Angeles, 4650 Sunset Blvd. MS #62, Los Angeles, CA 90027. E-mail: clutzko{at}chla.usc.edu.

Development of gene transfer vectors with regulated, lung-specific expression will be a useful tool for studying lung biology and developing gene therapies. In this study we constructed a series of lentiviral vectors with regulatory elements predicted to produce lung-specific transgene expression: the surfactant protein C promoter (SPC) for alveolar epithelial type II cell (AECII) expression, the Clara cell 10-kD protein (CC10) for Clara cell expression in the airway, and the Jaagskiete sheep retrovirus (JSRV) promoter for expression in both cell types. Transgene expression from the SPC and CC10 vectors was restricted to AECII and Clara cell lines, respectively, while expression from the JSRV vector was observed in multiple respiratory and nonrespiratory cell types. After intratracheal delivery of lentivector supernatant to mice, transgene expression was observed in AECII from the SPC lentivector, and in Clara cells from the CC10-promoted lentivector. Transgene expression was not detected in nonrespiratory tissues after intravenous delivery of CC10 and SPC lentiviral vectors to murine recipients. In summary, incorporation of genomic regulatory elements from the SPC and CC10 genes resulted in respiratory specific transgene expression in vitro and in vivo. These vectors will provide a useful tool for the study of lung biology and the development of gene therapies for lung disorders.

Key Words: gene therapy • lentivirus vector • regulated gene expression


CLINICAL RELEVANCE

These vectors will improve the safety of lung gene therapy applications. They will also be useful to basic scientists, to direct lung-specific expression of genes and/or track the progeny of transduced stem cells.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  CCM abstracts